U.S. Pharma Stock News

Ford Motor stock snapshot Ford Motor (F) has drawn investor attention after recent share weakness, with the stock showing negative returns over the past week, month, and past 3 months while still carrying a positive 1 year total return. See our latest analysis for Ford Motor. Recent share price momentum has faded, with a 30 day share price return of 17.07% and a 90 day share price return of 14.34%, while the 1 year total shareholder return of 24.11% remains positive. If Ford's recent pullback...

Veracyte, Inc. recently appointed Kevin Haas, Ph.D., as its first Chief Development and Technology Officer, tasking him with overseeing end-to-end product development across diagnostic assays, software, bioinformatics and program management to support its expanding global portfolio of laboratory-developed tests and in vitro diagnostic products. This new role, filled by a leader with deep experience in automated lab technology, AI and genomics platforms, underscores Veracyte’s intent to more...

Tenaya partnership broadens Alnylam’s reach into cardiovascular research The new collaboration between Alnylam Pharmaceuticals (ALNY) and Tenaya Therapeutics gives Alnylam access to up to 15 cardiovascular gene targets. Tenaya will handle early validation, while Alnylam will fund and lead downstream drug development. Tenaya is set to receive up to US$10 million upfront plus cost reimbursement over a two-year validation period. The company may also earn as much as US$1.13 billion in...

Institutional exit and insider sales draw attention to CMS Energy (CMS) Recent filings show Capital International Investors cut its CMS Energy (CMS) stake by 97.4%, alongside increased insider selling by executives, drawing fresh attention to ownership trends around the Michigan based utility. See our latest analysis for CMS Energy. At a share price of US$78.27, CMS Energy has delivered an 11.2% year to date share price return and a 10.1% 1 year total shareholder return. The 3 year total...

Earlier this month, Averna announced it had partnered with Curtiss-Wright to build five custom aerospace test systems that integrate secure data management and Curtiss-Wright's manufacturing execution systems for precision, safety-critical applications. This collaboration highlights how Curtiss-Wright is leaning on specialist automation expertise to enhance its production capabilities for Tier 1 aerospace programs and demanding defense customers. Next, we'll examine how this new aerospace...

In the past quarter, Hubbell reported fourth-quarter 2025 results with adjusted EPS of $4.73 and a 12% revenue increase, supported by strong data center and utility demand. Management’s emphasis on grid modernization, electrification, and a long record of growing dividends highlights how Hubbell is aligning operations with long-term infrastructure trends while reinforcing income appeal. Now we’ll examine how Hubbell’s earnings beat and upbeat 2026 growth guidance may influence its existing...

In early March 2026, Griffon Corporation reported its first-quarter fiscal 2026 results and again lowered its earnings outlook, citing a cooling housing market and tougher comparisons to prior high-growth periods. This repeated guidance cut highlights how sensitive Griffon’s performance is to housing-related demand, potentially testing earlier expectations for margin improvement and earnings expansion. We’ll now examine how this renewed earnings downgrade, set against cooling housing...

In recent days, The Times’ publication of extracts that prompted a high-profile response from the Duke and Duchess of Sussex concentrated reader attention on royal coverage, while Google faced renewed calls from European publishers including News Corp for EU regulators to conclude a long-running antitrust probe and impose penalties. Together, this surge in engagement around royal news and News Corp’s prominent role in pushing EU scrutiny of Google underscores how its UK media reach and...

Earlier in March 2026, Illumina announced a collaboration with Veritas Genetics Powered By Fuze Health to integrate whole-genome sequencing into preventive healthcare via insurance plans, while also advancing a large-scale multiomic drug discovery effort through its expanded Alliance for Genomic Discovery with Nashville Biosciences and new pharma partners. Together, these initiatives aim to make clinical-grade genomics and proteomics part of routine care and research, creating a large,...

Forgent Power Solutions (FPS) is back in focus after its fiscal second quarter and updated 2026 guidance, as strong revenue, bookings and backlog figures drew fresh attention from both the market and analysts. See our latest analysis for Forgent Power Solutions. The latest Q2 earnings release and 2026 revenue guidance helped push Forgent Power Solutions’ 1 day share price return to 11.6%, contributing to a 19.2% year to date share price return and signaling strengthening momentum. If you are...

NXP Semiconductors (NasdaqGS:NXPI) has drawn fresh attention after its board approved a US$1.014 interim dividend per share, paired with quarterly revenue growth above analyst estimates and an amended US$3b revolving credit agreement. See our latest analysis for NXP Semiconductors. Despite the fresh dividend announcement and new product updates in AI enabled processors, NXP Semiconductors' 30 day share price return of 21.49% decline and year to date share price return of 13.28% decline...

Cogent Biosciences (COGT) is in focus after the FDA accepted its New Drug Application for bezuclastinib in Non-Advanced Systemic Mastocytosis and set a PDUFA target action date of December 30, 2026. See our latest analysis for Cogent Biosciences. The FDA’s acceptance of the bezuclastinib NDA comes after a mixed stretch for the share price, with a 1-day share price return of 4.94% but a 90-day share price return decline of 10.78%. The 1-year total shareholder return is very large, indicating...

Why Ensign Group is on investors’ radar today Ensign Group (ENSG) has drawn attention after recent share price moves, with the stock showing mixed short term performance alongside stronger gains over the past 3 months and year. See our latest analysis for Ensign Group. At the current share price of $209.46, Ensign Group’s recent 1 day and 1 month share price returns have softened slightly. However, the 90 day share price return of 19.45% and 1 year total shareholder return of 61.61% suggest...

Intercontinental Exchange (ICE) has been in focus after a new relationship and investment in OKX, plans for container freight futures, fresh mortgage tech integrations, and fresh data on US$205b of homeowner equity withdrawals. See our latest analysis for Intercontinental Exchange. ICE’s recent OKX investment, planned container freight futures and mortgage technology integrations come as the share price trades at US$161.49, with a 30 day share price return of 6.05% but a 1 year total...

Cboe Global Markets (CBOE) has put fresh attention on its stock with two new product moves: a planned bitcoin volatility index and a new prediction market framework that reshapes outcome-based trading payouts. See our latest analysis for Cboe Global Markets. The latest product announcements come as momentum in the stock has been building, with a 90-day share price return of 15.67% and a 1-year total shareholder return of 34.32%, while multi year total returns remain strong overall. If news...

Pampers, Procter & Gamble’s flagship baby-care brand, recently launched Pampers AMORE in the US, its most premium and most absorbent diaper line since Pampers Pure in 2018, featuring five-layer protection, clinically proven hypoallergenic materials, and transparent ingredient claims for newborns through toddlers. This launch underscores Procter & Gamble’s push further into the high-end diaper segment, where advanced performance and safety credentials can help deepen brand loyalty among...

Navigator Holdings Ltd. reported its fourth-quarter and full-year 2025 results, with Q4 revenue rising to US$152.83 million while quarterly net income eased to US$18.48 million, and full-year net income increased to US$100.12 million on revenue of US$586.96 million. Alongside record annual profitability, the company raised its fixed dividend and expanded its capital return policy, signaling confidence in its balance sheet and in the earnings power of its liquefied gas fleet and export...

Astronics wins Boeing 737 MAX fuel tank access door contract Astronics (ATRO) drew fresh attention after Boeing selected the company to supply fuel tank access doors for the 737 MAX program, further linking its Clackamas, Oregon facility to a key commercial platform. See our latest analysis for Astronics. The Boeing contract lands as Astronics trades at US$68.70, with a 1 day share price return of 7.46%, following a 30 day share price return decline of 10.71%, and a 1 year total shareholder...

Solaris Energy Infrastructure recently closed two deals that will add about 900 MW of new natural gas-fueled turbine capacity by 2029, including the acquisition of Genco Power Solutions and the purchase of 30 turbine delivery slots, funded through a mix of cash, new shares, assumed debt, and a new US$300 million credit facility. This expansion program will lift Solaris’s total operated power generation capacity to roughly 3,100 MW by 2029 and commits the company to approximately US$935...

W. R. Berkley (WRB) is back in focus after a softer Q4, with revenue and book value per share missing forecasts while earnings per share matched estimates, yet the share price has firmed. See our latest analysis for W. R. Berkley. At a share price of US$68.53, W. R. Berkley has given investors a modest year to date share price decline alongside a 1 year total shareholder return of 9.8%, while the 5 year total shareholder return of 137.02% points to strong compounding over time. The recent...

Spyre Therapeutics recently reported that it has completed recruitment for the rheumatoid arthritis (RA) sub-study of its SKYWAY Phase 2 basket trial evaluating SPY072, an extended half-life TL1A-targeting antibody, and has accelerated the expected timing of topline proof-of-concept data to the third quarter of 2026 for RA and the fourth quarter of 2026 for psoriatic arthritis and axial spondyloarthritis. This progress underscores how basket and platform trial designs could speed clinical...

Installed Building Products (IBP) has drawn fresh investor attention after reporting earnings supported by its heavy commercial segment, even as single-family housing and private non-residential development remain areas of uncertainty for the business. See our latest analysis for Installed Building Products. The current share price of $288.33 comes after a 16.23% 1 month share price decline and a 3.66% 7 day pullback, even though the 1 year total shareholder return of 70.83% and 3 year total...

Analyst actions and operational momentum APA (APA) has moved into focus after several banks adjusted their views, pairing rating affirmations with higher price targets as management reported earlier than expected cost cuts and steady operational updates. See our latest analysis for APA. Those earlier cost cuts and consistent production updates have coincided with a sharp shift in sentiment, with a 30 day share price return of 23.71% and a 1 year total shareholder return of 81.35% suggesting...

Conference spotlight and mixed corporate signals for Service Corporation International Service Corporation International (SCI) is in focus after a mixed set of developments, including a quarterly earnings miss on both adjusted EPS and revenue, a new cash dividend, and insider share sales. See our latest analysis for Service Corporation International. Recent events around the earnings miss, new dividend, and insider sale appear to have checked enthusiasm, with the share price roughly flat over...